Company profile for Amplo Biotechnology

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Amplo Biotechnology is the developer of Adeno-Associated Viral (AAV) therapies designed to focus on cures for defects related to the neuromuscular junction. The company plans to develop multiple, potentially curative, Adeno-Associated Viral (AAV) therapies for the neuromuscular junction with an initial focus on congenital myasthenic syndromes. Amplo’s lead program, AMP-101 (AAV-Dok7), was developed by Professor Yuji Yamanash...
Amplo Biotechnology is the developer of Adeno-Associated Viral (AAV) therapies designed to focus on cures for defects related to the neuromuscular junction. The company plans to develop multiple, potentially curative, Adeno-Associated Viral (AAV) therapies for the neuromuscular junction with an initial focus on congenital myasthenic syndromes. Amplo’s lead program, AMP-101 (AAV-Dok7), was developed by Professor Yuji Yamanashi's group of the Institute of Medical Science at the University of Tokyo and is applicable to multiple rare, severe diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2637 East Atlantic Boulevard Suite 43644 Pompano Beach, FL 33062-4939
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/andelyn-biosciences-and-amplo-biotechnology-partner-to-manufacture-novel-gene-therapies-for-diseases-affecting-the-neuromuscular-junction-302535147.html

PR NEWSWIRE
21 Aug 2025

https://www.prnewswire.com/news-releases/amplo-biotechnology-announces-three-presentations-at-the-european-society-of-gene-and-cell-therapy-31st-annual-congress-302279179.html

PR NEWSWIRE
17 Oct 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty